Search

When emerging viruses cause severe diseases, the rapid development of vaccines and antivirals against these pathogens becomes critical. Some newly emerging viruses are very dangerous and necessitate the highest of biosafety levels for research and development purposes. DZIF scientists have a ...

Professor Thomas Krey’s research group aims to determine the structures of particular viral and cellular proteins that play a key role in the processes leading to infection. Consequently, the group is particularly focussed on the use of x-ray crystallography. Information regarding the structures of ...

The research group led by Dr. Angelika Riemer has set itself the goal of developing a functional therapeutic vaccine against human papillomavirus (HPV) infections and against HPV-induced tumors. While prophylactic vaccines induce the production of antibodies to prevent an infection with the pathogen ...

The Clinical Trials Platform at the Tübingen Institute of Tropical Medicine supports the development of new agents and vaccines against infectious diseases. It focuses on conducting experimental studies and first trials on humans. A special feature is the human malaria infection model, developed in ...

The CERMEL (Centre de Recherche Médical de Lambaréné) in Gabon is one of the leading establishments for malaria research in Africa. Clinical trials on vaccines and agents are tested according to the same approved guidelines that are used in Germany. A clinical research group was established within ...